Recombinant Human DNase (rhDNase) Influences Phospholipid Composition, Surface Activity, Rheology and Consecutively Clearance Indices of Cystic Fibrosis Sputum

Author： Griese M.   App E.M.   derouix A.   Burkert A.   Schams A.  

Publisher： Academic Press

ISSN： 1094-5539

Source： Pulmonary Pharmacology & Therapeutics, Vol.10, Iss.1, 1997-02, pp. : 21-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhalation of 1-Protease Inhibitor in Cystic Fibrosis does not affect Surfactant Convertase and Surface Activity

By Griese M.   von Bredow C.   Birrer P.   Schams A.  

Pulmonary Pharmacology & Therapeutics, Vol. 14, Iss. 6, 2001-12 ,pp. : 461-467

Academic Press

Access to resources Recommend Favorite

Recombinant Human Antithrombin III: rhATIII

By Adis International Limited  

Drugs in R&D, Vol. 5, Iss. 2, 2004-01 ,pp. : 110-112

Adis International

Access to resources Recommend Favorite

DNASE1L3 Mutations in Hypocomplementemic Urticarial Vasculitis Syndrome

By  

Arthritis & Rheumatism, Vol. 65, Iss. 8, 2013-08 ,pp. : 2183-2189

John Wiley & Sons Inc

Access to resources Recommend Favorite

The therapeutic potential of the human cystic fibrosis transmembrane conductance regulator gene

By Pavirani A.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 9, 1997-09 ,pp. : 1187-1192

Informa Healthcare

Access to resources Recommend Favorite

Drug Disposition in Cystic Fibrosis

By Rey E.   Tréluyer J-M.   Pons G.  

Clinical Pharmacokinetics, Vol. 35, Iss. 4, 1998-10 ,pp. : 313-329

Adis International

Access to resources Recommend Favorite